NEW YORK CITY, NY / ACCESSWIRE / January 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Visa Inc. (NYSE:V) between November 16, 2023 and September 23, 2024, both dates inclusive (the "Class Period"), of the important January 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Visa securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK CITY, NY / ACCESSWIRE / January 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients, Inc. (NASDAQ:MGPI) between May 4, 2023 and October 30, 2024 (the "Class Period"), of the important February 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased MGPI common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, NY / ACCESSWIRE / January 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, NY / ACCESSWIRE / January 11, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of stock of BioAge Labs, Inc. (NASDAQ:BIOA) pursuant and/or traceable to BioAge's initial public offering conducted on September 26, 2024 (the "IPO"). A class action lawsuit has already been filed.
NEW YORK, NY / ACCESSWIRE / January 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hasbro, Inc. (NASDAQ:HAS) between February 7, 2022 and October 25, 2023, both dates inclusive (the "Class Period"), of the important January 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased Hasbro common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK CITY, NY / ACCESSWIRE / January 10, 2025 / WHY: New York, N.Y., January 10, 2025.
NEW YORK, NY / ACCESSWIRE / January 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sun Communities, Inc. (NYSE:SUI) between February 28, 2019 and September 24, 2024, both dates inclusive (the "Class Period"), of the important February 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Sun Communities securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, NY / ACCESSWIRE / January 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Symbotic Inc. (NASDAQ:SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Symbotic securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK CITY, NY / ACCESSWIRE / January 10, 2025 / WHY: New York, N.Y., January 10, 2025.
NEW YORK, NY / ACCESSWIRE / January 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of stock of BioAge Labs, Inc. (NASDAQ:BIOA) pursuant and/or traceable to BioAge's initial public offering conducted on September 26, 2024 (the "IPO"). A class action lawsuit has already been filed.
NEW YORK CITY, NY / ACCESSWIRE / January 9, 2025 / WHY: New York, N.Y., January 9, 2025.
NEW YORK, NY / ACCESSWIRE / January 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) pursuant and/or traceable to Kyverna's initial public offering conducted on February 8, 2024 (the "IPO"), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.